Dual effect of inorganic polymeric phosphate/polyphosphate on osteoblasts and osteoclasts in vitro

Journal of Tissue Engineering and Regenerative Medicine

Volumn 7, Issue 10, 2013, Pages 767-776

  Wang, Xiaohong ^a,b   Schröder, Heinz C ^b,c   Diehl Seifert, Bärbel ^c   Kropf, Klaus ^c   Schlossmacher, Ute ^b   Wiens, Matthias ^b,c   Müller, Werner E G ^b,c  

^a INSTITUTE OF MINERAL RESOURCES   (China)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c NanotecMARIN GmbH   (Germany)

Author keywords

Hydroxyapatite formation; Inorganic polymeric phosphate; Osteoblastogenesis; Osteoblasts; Osteoclastogenesis; Osteoclasts; Polyphosphate; RAW 264.7 cells; SaOS 2 cells

Indexed keywords

BONE; CYTOLOGY; HYDROXYAPATITE; OSTEOBLASTS;

CA 2+; HYDROXYAPATITE FORMATIONS; INORGANIC POLYMERIC PHOSPHATE; INORGANICS; OSTEOBLASTOGENESIS; OSTEOCLAST; OSTEOCLASTOGENESIS; POLYPHOSPHATES; RAW 264.7 CELL; SAOS-2 CELLS;

PHOSPHATASES;

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BONE MORPHOGENETIC PROTEIN 2; CALCIUM CHLORIDE; HYDROXYAPATITE; I KAPPA B ALPHA; INORGANIC POLYMERIC PHOSPHATE; OSTEOCLAST DIFFERENTIATION FACTOR; POLYMER; POLYPHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE METABOLISM; CELL DIFFERENTIATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MINERALIZATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SCANNING ELECTRON MICROSCOPY;

HYDROXYAPATITE FORMATION; INORGANIC POLYMERIC PHOSPHATE; OSTEOBLASTOGENESIS; OSTEOBLASTS; OSTEOCLASTOGENESIS; OSTEOCLASTS; POLYPHOSPHATE; RAW 264.7 CELLS; SAOS-2 CELLS;

ANIMALS; ANTHRAQUINONES; BONE MORPHOGENETIC PROTEIN 2; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; DURAPATITE; HUMANS; I-KAPPA B PROTEINS; MICE; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; PHOSPHORYLATION; POLYMERS; POLYPHOSPHATES; RANK LIGAND; STAINING AND LABELING;

EID: 84885919579     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1465     Document Type: Article

References (70)

1. Abrams SA. 1998; Bone turnover during lactation - can calcium supplementation make a difference? J Clin Endocrin Metabol 83: 1056-1058.
2. Adkisson HD, Strauss-Schoenberger J, Gillis M et al. 2000; Rapid quantitative bioassay of osteoinduction. J Orthop Res 18: 503-511.
3. Albrektsson T, Johansson C. 2001; Osteoinduction, osteoconduction and osseointegration. Eur Spine J 10: S96-101.
4. Aldridge SE, Lennard TWJ, Williams JR et al. 2005; Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone. Br J Cancer 92: 1531-1537.
5. Bellows CG, Heersche JNM, Aubin JE. 1992; Inorganic phosphate added exogenously or released from β-glycerophosphate initiates mineralization of osteoid nodules in vitro. Bone Miner 17: 15-29.
6. Chen D, Zhao M, Mundy GR. 2004; Bone morphogenetic proteins. Growth Factors 22: 233-241.
7. Choi HJ, Park YR, Nepal M et al. 2010; Inhibition of osteoclastogenic differentiation by Ikarisoside A in RAW 264.7 cells via JNK and NF-κB signaling pathways. Eur J Pharmacol 636: 28-35.
8. Chung CH, Golub EE, Forbes E et al. 1992; Mechanism of action of β-glycerophosphate on bone cell mineralization. Calcif Tissue Int 51: 305-311.
9. Dudley AT, Robertson EJ. 1997; Overlapping expression domains of bone morphogenetic protein family members potentially account for limited tissue defects in BMP7-deficient embryos. Dev Dyn 208: 349-362.
10. Eliseev RA, Schwarz EM, Zuscik MJ et al. 2006; Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NFκB. Exp Cell Res 312: 40-50.
11. Endo A, Yamada M, Kataoka S et al. 2010; Direct observation of surface structure of mesoporous silica with low acceleration voltage FE-SEM. Colloids Surf A 357: 11-16.
12. Filgueira L. 2004; Fluorescence-based staining for tartrate-resistant acidic phosphatase (TRAP) in osteoclasts combined with other fluorescent dyes and protocols. J Histochem Cytochem 52: 411-414.
13. Fogh J, Fogh JM, Orfeo T. 1977; One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 59: 221-226.
14. Ghosh S, Karin M. 2002; Missing pieces in the NF-κB puzzle. Cell 109(suppl): S81-96.
15. Gregory CA, Gunn WG, Peister A et al. 2004; An alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem 329: 77-84.
16. Griffith EJ. 1995; Phosphate Fibers. Topics in Applied Chemistry Series. Springer: Berlin.
17. Hacchou Y, Uematsu T, Ueda O et al. 2007; norganic polyphosphate: a possible stimulant of bone formation. J Dent Res 86: 893-897.
18. Hamdona SK, Hamza SM. 2009; Influence of some phosphates and polyphosphate on the precipitation of calcium sulfate dihydrate in sodium chloride solutions. J Taibah Univ Sci 2: 44-51.
19. Han KY, Yang D, Chang EJ et al. 2007; Inhibition of osteoclast differentiation and bone resorption by sauchinone. Biochem Pharmacol 74: 911-923.
20. Hausser HJ, Brenner RE. 2005; Phenotypic instability of SaOS-2 cells in long-term culture. Biochem Biophys Res Commun 333: 216-222.
21. Imsiecke G, Münkner J, Lorenz B et al. 1996; Inorganic polyphosphates in the developing freshwater sponge Ephydatia muelleri: effect of stress by polluted waters. Environ Toxicol Chem 15: 1329-1334.
22. Islam S, Hassan F, Tumurkhuu G et al. 2008; Receptor activator of nuclear factor-κB ligand induces osteoclast formation in RAW 264.7 macrophage cells via augmented production of macrophage-colony-stimulating factor. Microbiol Immunol 52: 585-590.
23. Katchman BJ, Smith HE. 1958; Diffusion of synthetic and natural polyphosphates. Arch Biochem Biophys 76: 396-402.
24. + cells from cancer cell lines: chemotherapeutic implications. PLoS One 5: e10035; doi: 10.1371/journal.pone.0010035.
25. Kornberg A. 1999; Inorganic polyphosphate: a molecule of many functions. In Inorganic Polyphosphates: Biochemistry, Biology, Biotechnology, Schröder HC, Müller WEG (eds). Progress in Molecular and Subcellular Biology Series, vol 23. Springer: Berlin; 1-26.
26. Kulaev IS. 1979; The Biochemistry of Inorganic Polyphosphates. Wiley: New York.
27. Kulaev IS, Vagabov VM, Kulakovskaya TV. 2004; The Biochemistry of Inorganic Polyphosphates. Wiley: Chichester, UK; 1-277.
28. Lee ZH, Kim HH. 2003; Signal transduction by receptor activatior of nuclear factor-κB in osteoclasts. Biochem Biophys Res Commun 305: 211-214.
29. Lee J, Park JB, Herr Y et al. 2008; The effect of polyphosphate on exophytic bone formation. J Korean Acad Periodontol 38: 59-66.
30. Lee BH, Kim MC, Choi SH et al. 2009; Amorphous calcium polyphosphate bone regenerative materials based on calcium phosphate glass. Key Eng Mater 396-398: 209-212.
31. Leyhausen G, Lorenz B, Zhu H et al. 1998; Inorganic polyphosphate in human osteoblast-like cells. J Bone Miner Res 13: 803-812.
32. Liu G, Liu X, Yu J. 2010; Ammonium polyphosphate with crystalline form V by ammonium dihydrogen phosphate process. Ind Eng Chem Res 49: 5523-5529.
33. Lorenz B, Marmé S, Müller WEG et al. 1994a; Preparation and use of polyphosphate-modified zirconia for purification of nucleic acids and proteins. Anal Biochem 216: 118-126.
34. Lorenz B, Müller WEG, Kulaev IS et al. 1994b; Purification and characterization of an exopolyphosphatase activity from Saccharomyces cerevisiae. J Biol Chem 269: 22198-22204.
35. Lorenz B, Münkner J, Oliveira MP et al. 1997; Changes in metabolism of inorganic polyphosphate in rat tissues and human cells during development and apoptosis. Biochim Biophys Acta 1335: 51-60.
36. Morgan EF, Barnes GL, Einhorn TA. 2008; The bone organ system: form and function. In Osteoporosis, 3rd edn, Marcus R, Feldman D, Nelson D et al. (eds). Elsevier Academic: Boston, MA; 3-25.
37. Mori K, Berreur M, Blanchard F et al. 2007; Receptor activator of nuclear factor-κB ligand (RANKL) directly modulates the gene expression profile of RANK-positive Saos-2 human osteosarcoma cells. Oncol Rep 18: 1365-1371.
38. Morimoto D, Tomita T, Kuroda S et al. 2010; Inorganic polyphosphate differentiates human mesenchymal stem cells into osteoblastic cells. J Bone Miner Metab 28: 418-442.
39. Müller WEG, Boreiko A, Wang XH et al. 2007; Morphogenetic activity of silica and bio-silica on the expression of genes, controlling biomineralization using SaOS-2 cells. Calc Tissue Intern 81: 382-393.
40. 2+ level in osteoblasts (SaOS-2 cells) in vitro. Acta Biomater 7; 2661-2671.
41. Omelon SJ, Grynpas MD. 2008; Relationships between polyphosphate chemistry, biochemistry and apatite biomineralization. Chem Rev 108: 4694-4715.
42. Omelon S, Georgiou J, Henneman ZJ et al. 2009; Control of vertebrate skeletal mineralization by polyphosphates. PLoS One 4: e5634; doi: 10.1371/journal.pone.0005634.
43. Omoto M, Imai T, Seki K et al. 1997; The effect on the bones of condensed phosphate when used as food additives: its importance in relation to preventive medicine. Environ Health Prev Med 2: 105-116.
44. Quinn JM, Gillespie MT. 2005; Modulation of osteoclast formation. Biochem Biophys Res Commun 328: 739-745.
45. Rao NN, Gómez-Garcia MR, Kornberg A. 2009; Inorganic polyphosphate: essential for growth and survival. Annu Rev Biochem 78: 605-647.
46. Robins SP, Bilezikian JP, Seibel MJ. 2006; Dynamics of Bone and Cartilage Metabolism: Principals and Clinical Applications. Academic Press: San Diego, CA.
47. Sachs L. 1984; Angewandte Statistik. Springer: Berlin; 242.
48. Schröder HC, Müller WEG (eds). 1999; Inorganic Polyphosphates. Biochemistry, Biology, Biotechnology, vol 23. Springer Verlag: Berlin and Heidelberg.
49. Schröder HC, Kurz L, Müller WEG et al. 2000; Polyphosphate in bone. Biochemistry (Moscow) 65: 296-303.
50. Schröder HC, Borejko A, Krasko A et al. 2005; Mineralization of SaOS-2 cells on enzymatically (Silicatein) modified bioactive osteoblast-stimulating surfaces. J Biomed Mat Res B Appl Biomater 75B: 387-392.
51. Shahidi F, Rubin LJ, Diosady LL et al. 1986; Effect of sequestering agents on lipid oxidation in cooked meats. Food Chem 21: 145-152.
52. Simonet WS, Lacey DL, Dunstan CR et al. 1997; Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89: 309-319.
53. Sinha KM, Yasuda H, Coombes MM et al. 2010; Regulation of the osteoblast-specific transcription factor Osterix by NO66, a Jumonji family histone demethylase. EMBO J 29: 68-79.
54. Sung B, Pandey MK, Aggarwal BB. 2007; Fisetin, an inhibitor of cyclin-dependent kinase 6, downregulates nuclear factor-κB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein regulated IκBα kinase activation. Mol Pharmacol 71: 1703-1714.
55. Sung B, Murakami A, Oyajobi BO et al. 2009; Zerumbone abolishes RANKL-induced NF-κB activation, inhibits osteoclastogenesis, and suppresses human breast cancer-induced bone loss in athymic nude mice. Cancer Res 69: 1477-1484.
56. Tanaka H, Nagai E, Murata H et al. 2001; Involvement of bone morphogenic protein-2 (BMP-2) in the pathological ossification process of the spinal ligament. Rheumatology 40: 1163-1168.
57. Teitelbaum SL. 2007; Osteoclasts: what do they do and how do they do it? Am J Pathol 170: 427-435.
58. Tsuda E, Goto M, Mochizuki S et al. 1997; Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 234: 137-142.
59. Usui Y, Uematsu T, Uchihashi T et al. 2010; Inorganic polyphosphate induces osteoblastic differentiation. J Dent Res 89: 504-509.
60. Van Wazer JR (ed.). 1958; Phosphorus and Its Compounds: Chemistry, vol 1. Interscience: New York.
61. Vincent C, Kogawa M, Findlay DM et al. 2009; The generation of osteoclasts from RAW 264.7 precursors in defined, serum-free conditions. J Bone Miner Metab 27: 114-119.
62. Wiens M, Koziol C, Hassanein HMA et al. 1998; Induction of gene expression of the chaperones 14-3-3 and HSP70 induced by PCB 118 (2, 3′, 4, 4′, 5-pentachlorobiphenyl) in the marine sponge Geodia cydonium: novel biomarkers for polychlorinated biphenyls. Mar Ecol Prog Ser 165: 247-257.
63. Wiens M, Wang XH, Schlossacher U et al. 2010a; Osteogenic potential of bio-silica on human osteoblast-like (SaOS-2) cells. Calcif Tissue Int 87: 513-524.
64. Wiens M, Wang XH, Schröder HC et al. 2010b; The role of biosilica in the osteoprotegerin/RANKL ratio in human osteoblast-like cells. Biomaterials 31: 7716-7725.
65. Williams G, Sallis JD. 1982; Structural factors influencing the ability of compounds to inhibit hydroxyapatite formation. Calcif Tissue Int 34: 169-177.
66. Wittrant Y, Theoleyre S, Couillaud S et al. 2004a; Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-κB ligand and osteoprotegerin biological activities. Exp Cell Res 293: 292-301.
67. Wittrant Y, Theoleyre S, Chipoy C et al. 2004b; RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis. Biochim Biophys Acta 1704: 49-57.
68. Wood HG, Clark JE. 1988; Biological aspects of inorganic polyphosphates. Annu Rev Biochem 57: 235-260.
69. Young A, Phipps DE, Astroff AB. 2000; Large-scale double-staining of rat fetal skeletons using Alizarin Red S and Alcian Blue. Teratology 61: 273-276.
70. Zhou Z, Han JY, Xi CX et al. 2008; HMGB1 regulates RANKL-induced osteoclastogenesis in a manner dependent on RAGE. J Bone Miner Res 23: 1084-1096.